These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30302818)

  • 1. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
    Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
    Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10.
    Nozaki E; Kobayashi T; Ohnishi H; Ohtsuka K; Masaki T; Watanabe T; Sugiyama M
    Oncol Lett; 2020 Mar; 19(3):2495-2501. PubMed ID: 32194750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR3A contributes to the invasion and metastasis of gastric cancer cells.
    Yang C; Zheng W; Du W
    Oncol Rep; 2016 Sep; 36(3):1686-92. PubMed ID: 27461521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
    Wu Q; Dhir R; Wells A
    Mol Cancer; 2012 Jan; 11():3. PubMed ID: 22236567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of CXCR3 in proliferation and invasion of prostate cancer cells.
    Shen D; Cao X
    Int J Clin Exp Pathol; 2015; 8(7):8091-8. PubMed ID: 26339376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization.
    Jin J; Zhang Z; Wang H; Zhan Y; Li G; Yang H; Fei Z; Xu Y; Li W
    Exp Cell Res; 2018 Oct; 371(1):162-174. PubMed ID: 30092218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-X-C Motif Chemokine Receptor 3 Splice Variants Differentially Activate Beta-Arrestins to Regulate Downstream Signaling Pathways.
    Smith JS; Alagesan P; Desai NK; Pack TF; Wu JH; Inoue A; Freedman NJ; Rajagopal S
    Mol Pharmacol; 2017 Aug; 92(2):136-150. PubMed ID: 28559424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α1 promotes tumorigenicity and progressive capacity of colorectal cancer.
    Li H; Wang Y; Rong SK; Li L; Chen T; Fan YY; Wang YF; Yang CR; Yang C; Cho WC; Yang J
    Int J Biol Sci; 2020; 16(5):815-826. PubMed ID: 32071551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 isoform A promotes head and neck cancer progression by enhancing stem-like property and chemoresistance.
    Sun WH; Peng TJ; Tang SJ; Lin JY; Wang CY; Fang HJ; Sun KH
    J Oral Pathol Med; 2022 Oct; 51(9):791-800. PubMed ID: 35998229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Analysis of CXCR3 Splicing Variants and Their Ligands Using NanoBiT-Based Molecular Interaction Assays.
    Nguyen HT; Hurh S; Nguyen LP; Nguyen TU; Park HK; Seong JY; Lee CS; Ham BJ; Hwang JI
    Mol Cells; 2023 May; 46(5):281-297. PubMed ID: 36799104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
    Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
    Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
    Puchert M; Obst J; Koch C; Zieger K; Engele J
    Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha2b restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by modulating CXC receptor ligand interaction.
    Chakraborty K; Bose A; Pal S; Chattopadhyay U; Baral R
    J Interferon Cytokine Res; 2008 Aug; 28(8):487-99. PubMed ID: 18729739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
    Wang W; Xing C
    Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.
    Furuya M; Yoneyama T; Miyagi E; Tanaka R; Nagahama K; Miyagi Y; Nagashima Y; Hirahara F; Inayama Y; Aoki I
    Gynecol Oncol; 2011 Sep; 122(3):648-55. PubMed ID: 21684584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
    Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.